http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101190248-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_969b0298381b88db866eaceed16d275d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 |
| filingDate | 2006-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_580c6be3f3f78644578008c668abbe70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6932dca435d8c37bb6edcbe5975f9b0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ce2e48bae3fec7368c263baef984dac |
| publicationDate | 2013-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-101190248-B |
| titleOfInvention | Long chain fatty milk in camelina sativa oil orally-administered or injection preparations |
| abstract | An oral or injection preparation of the medium and long-chain fat emulsion of Camelina sativa oil relates to a medical care and nutritional fat emulsion product which contains Camelina sativa oil and is prepared according to prescription. The weight proportion of the invention is: 0.1 percent to 20 percent of Camelina sativa oil which is taken as medicine, 0 percent to 20 percent of MCT which is taken as rapid energy-provision agent, 0 percent and 15 percent of lecithin which is taken as emulsifier, 0 percent and 30 percent of refined oil which is taken as oil solvent and 0.15 to 0.25 percent of glycerin which is taken as isoosmotic adjustment agent, and water for injection is added till the total amount reaches 1000g; wherein, the final osmotic pressure of glycerin which is taken as isoosmotic adjustment agent is 0.5 to 3 isotonic concentration. The invention has the advantages that the preparation not only satisfies the fundamental needs of the human body on essential fatty acid, but also can greatly reduce the adverse effects caused by excessive polyunsaturated fatty acid and saturated fatty acid simultaneously. Compared with the common soybean oil fat emulsion, the invention can reduce lipid peroxidation to the utmost degree, improve immunity, increase the level of the active vitamin E Alpha-tocopherol in the human body, enhance the stability of the emulsion and speed up the synthesis of long-chain fatty acids. |
| priorityDate | 2006-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 196.